¹³¹I-labelled Anti-CD22 MAb (LL2) in Patients with B-Cell Lymphomas Failing Chemotherapy

Author： Lindén Ola Tennvall Jan Hindorf Cecilia Cavallin-Ståhl Eva Lindner Karl-Johan Ohlsson Tomas Wingårdh Karin Strand Sven-Erik

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.41, Iss.3, 2002-05, pp. : 297-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies

By Dillman R.

Clinical and Experimental Medicine, Vol. 6, Iss. 1, 2006-03 ,pp. : 1-12

Springer Publishing Company

Access to resources Recommend Favorite

The combination of milatuzumab, a humanized anti‐CD74 antibody, and veltuzumab, a humanized anti‐CD20 antibody, demonstrates activity in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 701-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy

By Seshadri T. Stakiw J. Pintilie M. Keating A. Crump M. Kuruvilla J.

Hematology, Vol. 13, Iss. 5, 2008-10 ,pp. : 261-266

Maney Publishing

Access to resources Recommend Favorite

Anti-CD3 induces splenic B220 lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization

By Todo Tsuyoshi Wu Gordon Chai Ning-ning He Yao Martins Gislaine Gupta Ankur Fair Jeffrey Liu Nai-you Jordan Stanley Klein Andrew

International Immunology, Vol. 24, Iss. 8, 2012-08 ,pp. : 529-538

Oxford University Press

Access to resources Recommend Favorite

Immunotherapy in the B-cell lymphomas

By Gribben JG

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 439-440

Ashgate Publishing Ltd

Access to resources Recommend Favorite